Condition: Pediatric Cancer · Sponsor: Universitaire Ziekenhuizen KU Leuven
It involves collecting safety and efficacy data, under the actual conditions of use of off label and compassionate use medicines in children and adolescents approved in humans before 2007, using a validated tool (Ennov EDC) and relying on the network recognised pediatric hemato-oncology centers in Belgium and responsible for the organization of Pediatric National tumor boards which discuss each case of relapse in order to define the best therapeutic options.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University Hospital Antwerp | Antwerp, Belgium | Not Yet Recruiting |
| Hôpital Universitaire des Enfants Reine Fabiola (HUDERF) | Brussels, Belgium | Not Yet Recruiting |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Not Yet Recruiting |
| University Hospital Gent | Ghent, Belgium | Not Yet Recruiting |
| University Hospital Leuven | Leuven, Belgium | Recruiting |
| CHC Montlégia | Liège, Belgium | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07727694